Met Life Investment Management, LLC Bridge Bio Pharma, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 81,166 shares of BBIO stock, worth $2.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
81,166
Previous 81,166 -0.0%
Holding current value
$2.32 Million
Previous $2.06 Million 0.54%
% of portfolio
0.01%
Previous 0.01%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$23.0 - $31.04 $505,724 - $682,507
21,988 Added 37.16%
81,166 $2.06 Million
Q1 2024

May 14, 2024
BUY
$27.35 - $40.45 $1.62 Million - $2.39 Million
59,178 New
59,178 $1.83 Million
Q3 2023

May 09, 2024
BUY
$16.89 - $35.01 $79,703 - $165,212
4,719 Added 8.48%
60,390 $1.59 Million
Q2 2023

Apr 29, 2024
BUY
$13.29 - $18.01 $802,583 - $1.09 Million
60,390 New
60,390 $1.04 Million
Q2 2023

Aug 10, 2023
BUY
$13.29 - $18.01 $62,715 - $84,989
4,719 Added 8.48%
60,390 $1.04 Million
Q1 2023

May 09, 2024
BUY
$7.17 - $18.55 $399,161 - $1.03 Million
55,671 New
55,671 $923 Million
Q1 2023

May 15, 2023
SELL
$7.17 - $18.55 $19,882 - $51,439
-2,773 Reduced 4.74%
55,671 $923,000
Q4 2022

Jun 14, 2023
BUY
$6.74 - $11.52 $18,690 - $31,944
2,773 Added 4.98%
58,444 $445,000
Q3 2022

Jun 14, 2023
BUY
$7.94 - $12.36 $22,017 - $34,274
2,773 Added 4.98%
58,444 $580,000
Q2 2022

Jun 20, 2023
BUY
$5.21 - $12.14 $14,447 - $33,664
2,773 Added 4.98%
58,444 $530,000
Q1 2022

May 10, 2024
BUY
$7.34 - $17.16 $428,978 - $1 Million
58,444 New
58,444 $593,000
Q1 2022

Jun 20, 2023
BUY
$7.34 - $17.16 $20,353 - $47,584
2,773 Added 4.98%
58,444 $593,000
Q1 2022

Mar 22, 2023
BUY
$7.34 - $17.16 $147,658 - $345,207
20,117 Added 52.49%
58,444 $593,000
Q1 2022

May 12, 2022
BUY
$7.34 - $17.16 $147,658 - $345,207
20,117 Added 52.49%
58,444 $593,000
Q4 2021

Jun 21, 2023
SELL
$11.38 - $53.41 $197,374 - $926,343
-17,344 Reduced 31.15%
38,327 $639,000
Q3 2021

Jun 21, 2023
SELL
$46.87 - $64.24 $812,913 - $1.11 Million
-17,344 Reduced 31.15%
38,327 $1.8 Million
Q2 2021

May 17, 2024
BUY
$46.47 - $63.93 $179,420 - $246,833
3,861 Added 11.2%
38,327 $2.34 Million
Q2 2021

Jun 21, 2023
SELL
$46.47 - $63.93 $805,975 - $1.11 Million
-17,344 Reduced 31.15%
38,327 $2.34 Million
Q2 2021

Mar 22, 2023
BUY
$46.47 - $63.93 $179,420 - $246,833
3,861 Added 11.2%
38,327 $2.34 Million
Q2 2021

Aug 16, 2021
BUY
$46.47 - $63.93 $179,420 - $246,833
3,861 Added 11.2%
38,327 $2.34 Million
Q1 2021

May 17, 2024
SELL
$55.47 - $72.35 $1.37 Million - $1.79 Million
-24,712 Reduced 41.76%
34,466 $2.12 Million
Q1 2021

Jun 26, 2023
SELL
$55.47 - $72.35 $1.18 Million - $1.53 Million
-21,205 Reduced 38.09%
34,466 $2.12 Billion
Q1 2021

Mar 22, 2023
BUY
$55.47 - $72.35 $255,439 - $333,171
4,605 Added 15.42%
34,466 $2.12 Million
Q1 2021

May 14, 2021
BUY
$55.47 - $72.35 $255,439 - $333,171
4,605 Added 15.42%
34,466 $2.12 Million
Q4 2020

May 24, 2024
SELL
$38.38 - $71.11 $85,856 - $159,073
-2,237 Reduced 6.97%
29,861 $2.12 Million
Q4 2020

Jun 22, 2023
SELL
$38.38 - $71.11 $990,587 - $1.84 Million
-25,810 Reduced 46.36%
29,861 $2.12 Million
Q4 2020

Mar 22, 2023
SELL
$38.38 - $71.11 $85,856 - $159,073
-2,237 Reduced 6.97%
29,861 $2.12 Million
Q4 2020

Feb 16, 2021
SELL
$38.38 - $71.11 $85,856 - $159,073
-2,237 Reduced 6.97%
29,861 $2.12 Million
Q3 2020

Jun 26, 2023
SELL
$27.2 - $42.19 $641,185 - $994,544
-23,573 Reduced 42.34%
32,098 $1.2 Million
Q2 2020

May 24, 2024
SELL
$22.22 - $35.69 $601,717 - $966,485
-27,080 Reduced 45.76%
32,098 $1.05 Billion
Q2 2020

Jun 26, 2023
SELL
$22.22 - $35.69 $523,792 - $841,320
-23,573 Reduced 42.34%
32,098 $1.05 Million
Q1 2020

Jul 12, 2023
SELL
$16.11 - $36.23 $379,761 - $854,049
-23,573 Reduced 42.34%
32,098 $930,000
Q1 2020

Mar 22, 2023
BUY
$16.11 - $36.23 $352,212 - $792,096
21,863 Added 213.61%
32,098 $930,000
Q1 2020

May 15, 2020
BUY
$16.11 - $36.23 $352,212 - $792,096
21,863 Added 213.61%
32,098 $931,000
Q4 2019

Jul 12, 2023
SELL
$17.96 - $46.63 $816,030 - $2.12 Million
-45,436 Reduced 81.62%
10,235 $358,000
Q4 2019

Mar 22, 2023
SELL
$17.96 - $46.63 $84,088 - $218,321
-4,682 Reduced 31.39%
10,235 $358,000
Q4 2019

Feb 14, 2020
SELL
$17.96 - $46.63 $84,088 - $218,321
-4,682 Reduced 31.39%
10,235 $359,000
Q3 2019

Jul 12, 2023
SELL
$20.13 - $32.38 $820,378 - $1.32 Million
-40,754 Reduced 73.21%
14,917 $320,000
Q3 2019

Mar 22, 2023
SELL
$20.13 - $32.38 $876,198 - $1.41 Million
-43,527 Reduced 74.48%
14,917 $320,000
Q3 2019

Nov 14, 2019
BUY
$20.13 - $32.38 $300,279 - $483,012
14,917 New
14,917 $320,000

Others Institutions Holding BBIO

# of Institutions
290
Shares Held
170M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email